Phase Ib Dose Finding Study of BKM 120 in Combination With LH-RH Agonists and Bicalutamide in Men With Non Castrate Metastatic Prostate Cancer
Phase of Trial: Phase I
Latest Information Update: 07 Mar 2017
At a glance
- Drugs Buparlisib (Primary) ; Bicalutamide; LHRH receptor agonists
- Indications Prostate cancer
- Focus Adverse reactions
- Acronyms NCMPC-BKM
- 01 Mar 2017 Planned End Date changed from 1 Jan 2017 to 1 Sep 2017.
- 01 Mar 2017 Planned primary completion date changed from 1 Jan 2017 to 1 Aug 2017.
- 30 Jan 2017 Status changed from recruiting to discontinued.